PEX19
Basic information
Region (hg38): 1:160276807-160286348
Previous symbols: [ "PXF" ]
Links
Phenotypes
GenCC
Source:
- peroxisome biogenesis disorder 1A (Zellweger) (Definitive), mode of inheritance: AR
- peroxisome biogenesis disorder 12A (Zellweger) (Strong), mode of inheritance: AR
- Zellweger spectrum disorders (Supportive), mode of inheritance: AR
- peroxisome biogenesis disorder 12A (Zellweger) (Moderate), mode of inheritance: AR
- peroxisome biogenesis disorder 12A (Zellweger) (Definitive), mode of inheritance: AR
- peroxisome biogenesis disorder (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Peroxisome biogenesis disorder, 19; Zellweger syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Renal | 9727033; 10051604; 20683989 |
ClinVar
This is a list of variants' phenotypes submitted to
- Peroxisome biogenesis disorder 12A (Zellweger) (7 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEX19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 66 | 68 | ||||
missense | 153 | 154 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 3 | 19 | 22 | |||
non coding | 43 | 51 | 15 | 109 | ||
Total | 8 | 9 | 204 | 117 | 15 |
Highest pathogenic variant AF is 0.00000657
Variants in PEX19
This is a list of pathogenic ClinVar variants found in the PEX19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-160276834-T-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160276914-C-T | Peroxisome biogenesis disorder 12A (Zellweger) | Benign (Jan 12, 2018) | ||
1-160276996-A-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277015-T-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277128-CAG-C | Peroxisome biogenesis disorder 1A (Zellweger) | Uncertain significance (Jun 14, 2016) | ||
1-160277134-G-A | Peroxisome biogenesis disorder 12A (Zellweger) | Benign (Jan 12, 2018) | ||
1-160277138-G-A | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277168-G-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160277198-C-A | Peroxisome biogenesis disorder 12A (Zellweger) | Benign (Jan 12, 2018) | ||
1-160277327-C-A | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277395-G-C | Peroxisome biogenesis disorder 12A (Zellweger) | Benign (Jan 12, 2018) | ||
1-160277396-G-A | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277483-A-G | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160277494-A-C | Peroxisome biogenesis disorder 12A (Zellweger) | Likely benign (Apr 27, 2017) | ||
1-160277571-A-G | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277699-G-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
1-160277749-C-G | Peroxisome biogenesis disorder 12A (Zellweger) | Likely benign (Jan 13, 2018) | ||
1-160277761-T-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160277790-G-T | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160277806-A-G | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160277959-C-T | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160278080-T-A | Peroxisome biogenesis disorder 12A (Zellweger) | Benign (Apr 27, 2017) | ||
1-160278089-G-C | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160278101-A-T | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
1-160278216-C-A | Peroxisome biogenesis disorder 12A (Zellweger) | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PEX19 | protein_coding | protein_coding | ENST00000368072 | 8 | 9537 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000319 | 0.950 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.776 | 190 | 162 | 1.17 | 0.00000837 | 1984 |
Missense in Polyphen | 51 | 51.81 | 0.98437 | 691 | ||
Synonymous | -0.668 | 70 | 63.2 | 1.11 | 0.00000377 | 555 |
Loss of Function | 1.75 | 8 | 15.4 | 0.518 | 6.70e-7 | 194 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000277 | 0.000277 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. {ECO:0000269|PubMed:10051604, ECO:0000269|PubMed:10704444, ECO:0000269|PubMed:11259404, ECO:0000269|PubMed:11883941, ECO:0000269|PubMed:14709540, ECO:0000269|PubMed:15007061}.;
- Disease
- DISEASE: Peroxisome biogenesis disorder 12A (PBD12A) [MIM:614886]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269|PubMed:10051604}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Peroxisome - Homo sapiens (human);ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.255
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.333
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pex19
- Phenotype
Gene ontology
- Biological process
- protein targeting to peroxisome;peroxisome organization;peroxisome fission;protein import into peroxisome membrane;protein stabilization;transmembrane transport;chaperone-mediated protein folding;chaperone-mediated protein transport;establishment of protein localization to peroxisome;negative regulation of lipid binding
- Cellular component
- nucleoplasm;cytoplasm;peroxisome;peroxisomal membrane;cytosol;brush border membrane;protein-containing complex
- Molecular function
- protein binding;peroxisome membrane class-1 targeting sequence binding;protein N-terminus binding;ATPase binding